At a MAHA Institute event, Kennedy and others argued that health data should be more accessible to researchers can study ...
Senate’s health committee doesn’t have a vote scheduled on the nominee to run the FDA.
UniQure's gene therapy continues to slow Huntington's progression after four years. But the magnitude of the benefit waned ...
Merck discontinued Recarbio, an important antibiotic in the U.S., despite concerns over resistance to superbugs.
The Trump administration asked the Supreme Court on Monday to let it enforce, for now, restrictions on gender-affirming care ...
Post-wildfire air quality needs to be monitored long term, suggests a study finding Maui residents had high levels of toxic ...
Defenses against AI-created bioweapons will take years to build. We don’t have years to spare,” writes Ashish Jha.
The FDA has approved AbbVie’s once-daily Parkinson’s pill for sales, based on a late-stage study that showed the drug helped ...
Late Friday night, the Trump administration clawed back nearly $1 billion in spending approved by Congress, targeting several ...
Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Intellia Therapeutics said Monday that a ...
Once promoted as tools to address obesity as a medical issue, GLP-1 drugs are increasingly being seen — and marketed — as a ...
Our finding was remarkable because it had remained hidden within one of the best-studied organs in medical history.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results